MedPath

Evaluating the Impact of Evidence-based Information About Mammography on Breast Cancer Screening Decisions

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Other: Evidence-based information
Other: Sham information
Behavioral: Patient Decision Aid
Registration Number
NCT03631758
Lead Sponsor
McMaster University
Brief Summary

Patient decision aids are tools that help guide individuals through a healthcare-related decision making process. They help users combine evidence-based information and recommendations by a health care provider with their personal needs, values and preferences. Through this project, Dr. Dobbins and her research team will explore whether the use of patient decision aids with high-quality and user-friendly summaries of research evidence, or summaries of research evidence alone, help to improve the quality of decision making by women facing breast cancer screening decisions.

Detailed Description

Guidelines for breast screening in Canada are based on low-moderate quality evidence of effectiveness and screening is associated with potential harms. Patient Decision Aids (PDAs) are tools that assist users to understand treatment options, risks and benefits to align decisions with values and preferences. The investigators would now like to know whether use of a PDA alongside evidence-based information provided through the McMaster Optimal Aging Portal, or simply access to evidence-based information alone, can help users to make informed decisions about breast cancer screening in women.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
209
Inclusion Criteria
  • English speaking women, 40-49 years old
  • Residents of British Columbia, Nova Scotia, and Prince Edward Island
Read More
Exclusion Criteria
  • History of breast cancer or mammography in the last 12 months
  • Classified as above-average risk for breast cancer (i.e., known genetic mutation linked to BC; no genetic testing, but a parent, sibling or child with a genetic mutation linked to BC; or received chest wall radiation before age 30)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental: Evidence + PDAEvidence-based informationEvidence-based information on mammography such as blog posts, plain language evidence summaries and web resource ratings (quality-appraised online resources), plus a blog post on PDAs and the relevant decision aid from the Portal database
Attention controlSham informationInformation on how to distinguish high from low-quality health information, not specific to cancer screening or PDAs
Evidence onlyEvidence-based informationThe same evidence-based information as group 1 (Evidence + PDA), but without the PDA to quantify the effect of accessing evidence through the Portal alone
Experimental: Evidence + PDAPatient Decision AidEvidence-based information on mammography such as blog posts, plain language evidence summaries and web resource ratings (quality-appraised online resources), plus a blog post on PDAs and the relevant decision aid from the Portal database
Primary Outcome Measures
NameTimeMethod
Decisional Conflict ScaleChange from baseline to 6-mo

A validated scale in which items are summed and scored to create a total score. Scores range from 0 to 100, with higher scores indicating higher decisional conflict.

Secondary Outcome Measures
NameTimeMethod
Preparation for Decision Making ScaleChange from baseline to 6-mo

A validated scale, items are summed and scored to create a score of 0-100. Higher scores indicate higher preparation for decision making

Screening behaviourChange from baseline to 6-mo

Congruency between self-reported screening status and stated decision

Decision qualityChange from baseline to 6-mo

Decision Quality Worksheet for Mammography

Trial Locations

Locations (1)

McMaster University

🇨🇦

Hamilton, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath